Parkar, A P and Kandiah, P 2016 Differential Diagnosis of Cavitary

Lung Lesions. Journal of the Belgian Society of Radiology, 100(1):

100, pp. 1–8, DOI: http://dx.doi.org/10.5334/jbr-btr.1202

PICTORIAL ESSAY

Differential Diagnosis of Cavitary Lung Lesions

Anagha P. Parkar* and Panchakulasingam Kandiah†

Many different diseases present as cavitary pulmonary nodules. The spectrum of diseases ranges from
acute to chronic infections, chronic systemic diseases, and malignancies. To decide on the most likely or
correct diagnosis may be challenging. Knowledge of common and uncommon radiological findings in
correlation with relevant clinical history and findings is necessary to make the right diagnosis and
recommend the correct follow-up or step forward. The aim of this pictorial review is to present a brief
overview of CT findings of common cavitary lung diseases seen in adult patients.

Keywords: Cavitary lung lesion; CT; Pulmonary infection; Pulmonary malignancy

A cavity is defined in the Fleischner glossary as “a gas-filled space, seen as a lucency or low-attenuation area, within
pulmonary consolidation, a mass, or a nodule” [1]. The cavity wall thickness may vary considerably. At their end-stage
presentation, some cavitary diseases may present thin-walled cavities, or cysts. One should remember that there is a
continuous transition from cavities to cysts. Cysts in the lungs are defined as “any round circumscribed space that is
surrounded by an epithelial or fibrous wall of variable thickness”. The glossary further defines them as usually thin walled
(i.e. < 2 mm) [1]. The wall thick-ness of the cavitary lung lesions in solitary disease can be useful in differentiating between
benign and malignant disorders. A recent study found that a wall thickness of less than 7 mm was highly specific for benign
disease, and a thickness of greater than 24 mm was highly spe-cific for malignant disease. However, these thresholds are not
absolute, as thin-walled carcinomas are also reported
[2]. An additional indicator for malignancy was the lack of perilesional centrilobular nodules, whereas perilesional
consolidation was common around benign nodules [3].
The content of the cavities is of little help in differentiat-ing benign and malignant lesions. A benign bronchogenic cyst
may contain fluid levels, as may a bronchoalveolar carcinoma. The degree of contrast enhancement in the content of nodules
(< 10 HU) is shown to indicate benign lesions and may be used to distinguish aspergillomas from lung cancer [4, 5]. Rim
enhancement of the walls on contrast-enhanced CT is common in abscesses [6]. A con-necting pulmonary artery may be seen
in smaller metas-tases but not in larger ones, as the larger nodules tend to

* Haraldsplass Deaconess Hospital, NO

† Haukeland University Hospital, NO
Corresponding author: Anagha P. Parkar ([email protected])
compress the vessels, so a lack of a feeding artery cannot be used to imply benign nodules [7].
The acute onset of symptoms is sometimes helpful to distinguish malignant and nonmalignant disease, but a benign
infection may, for instance, cause hemopty-sis when affecting a nearby vessel. Benign diseases may also cause fatigue
and weight loss similar to malignan-cies. Acute onset of fever is usually helpful to distinguish benign disorders from
malignancies, but a pulmonary cancer may present with a superinfection secondary to the tumor [8]. However, the
combination of symptoms, laboratory results, past clinical history, and imaging find-ings leads to recognition of the
correct diagnosis. This review presents the most commonly encountered cavitary lung diseases in adults in Europe.

Infections
Several groups of microorganisms may cause cavitary lesions: common bacteria (for example, Streptococcus p.,
Staph.aureus, Klebsiella p., H. influenzae); typical and atypical mycobacterium; fungi (for example, aspergillosis,
pneumocystis j.); and parasites [9].

Pulmonary Abscess
Pulmonary abscess occurs as a complication of pneumo-nia. Symptoms are consistent with pneumonia: productive cough,
fever, chest pain [10]. Most abscesses can be treated conservatively, but percutaneous drainage may be neces-sary in up to 20
per cent of cases [10]. In addition to such common complications as pneumothorax and empyema, the development of
broncho-pleural fistulas is a rare com-plication [11]. Abscesses are seen on CT as cavitary lesions with or without a fluid
level. They may occur anywhere in the lungs. Usually, intermediate to thick wall thickness with a peripheral contrast
enhancement and necrotizing centre is visible. If the abscess is located peripherally, there may be local pleural thickening or
an empyema (Figures 1–2).
Art. 100, pp.  2 of 8 Parkar and Kandiah: Differential Diagnosis of Cavitary Lung Lesions

Figure 1: Pulmonary abscess. A 36-year-old male was admitted with sepsis a week earlier. A CT was performed due
to low response to antibiotic treatment. A large cav-ity is seen in the right upper lobe with an air-fluid level (long
arrow). Rim enhancement is seen in the cavity wall anteriorly (short arrows). A pleural effusion is also seen (thick
arrow).

Figure 2: Pulmonary abscess. Same patient. The periph-eral location has caused a local empyema (arrows), and there
is also an enhancement of the pleura posteriorly, development of empyema (thick arrow).

Septic Emboli
Septic emboli occur when microorganisms cause throm-bosis in the peripheral pulmonary capillaries. Immuno-
suppressed patients, patients with arterial or intravenous catheters, intravenous drug abusers, and alcoholics and
patients with endocarditis or those undergoing dental sur-gery are susceptible to septic emboli. The thrombi lead to
infarction and consequent micro-abscesses. The patients are septic and have cough and dyspnea, chest pain, and
perhaps hemoptysis and sinus tachycardia [12]. The CT presentation consists of multiple peripheral nodular or wedge-
shaped opacities with a broad base against the pleura. The nodules develop rapidly into cavities (within
Figure 3: Septic emboli. A 29-year-old male and IV drug abuser was admitted with sepsis and dyspnea. There was a
peripheral cavitary lesion in the right lung (black arrow) and a wedge-shaped lesion in the left lung (yel-low arrow).

days). The dynamic development helps differentiate it from malignancies. The cavities may show peripheral con-trast
enhancement. Wall thickness may vary considerably and is of no help in distinguishing from other entities. Pleural
effusion is often present, which may develop into an empyema. Hilar and mediastinal lymphadenopathy may occur.
Additional imaging findings include widening of the pulmonary artery due to increased pressure. If the thrombi reach
the left heart, infarctions in the abdomi-nal parenchymal organs, brain, and skin may occur (Figures 3–6) [12, 13].

Mycobacterium Tuberculosis Infection

Tuberculosis has an increasing prevalence after years of some decline. The clinical manifestation may be subtle or
completely absent. Symptoms include low-grade fever, malaise, loss of weight, and, when the lungs are affected, cough, with
or without hemoptysis [14, 15]. The radiologi-cal division of primary and secondary features has been debunked [16].
However, a radiological pattern does exist; upper lobe cavitary disease is commonly seen in immu-nocompetent adults, while
lower lung zone disease, ade-nopathy, and pleural effusions are commonly found in immunocompromised patients (children
are considered in this group). The cavities in tuberculosis, which occur in 50 per cent of patients, are usually located in upper
zones of the lobes. They are often surrounded by satellite nod-ules [15]. The cavity wall thickness may vary considerably,
and the cavity wall may show rim enhancement on CT. If there is affection of the lymph nodes, one may see nodal rim
enhancement around central necrosis (Figures 7–9). Pleural effusion may occur and is seen in 25 per cent of patients [15].
Miliary tuberculosis is hematogenous spread of disease, which presents as small, 2–3 mm sized nodules. They are usually
located in the lower zones of the
lobes and may cavitate (Figure 10) [15].

Non-tuberculous Mycobacterial (NTMB) Infection

Atypical mycobacterial or non-tuberculous mycobacte-rial (NTMB) infections are caused by mycobacteria other than
Mycobacterium tuberculosis. They consist of dozens
Parkar and Kandiah: Differential Diagnosis of Cavitary Lung Lesions Art. 100, pp.  3 of 8

Figures 4–6: Septic emboli in the lungs and parenchymal organs. A 22-year-old male and IV drug abuser was admitted
with chest pain. Peripheral nodules are seen, with an enlarged pulmonary artery, as well as infarctions in the spleen
and right kidney (arrows) due to aortic endocarditis.

Figure 7: Tuberculosis. This 68-year-old male previously lived in areas of endemic tuberculosis. He was admit-ted
with productive cough and fever in the evening in the past two weeks. Now he has hemoptysis with a C-reactive
protein level of 120 mg/L. The initial radio-graph showed a cavity. CT with contrast showed a fluid-filled cavity in
the upper right lung, with faint contrast enhancement in the wall.

Figure 8: Rim enhancement is seen in the enlarged medi-astinal lymph node.

of different organisms, the most common are M. avium-intracelluare and M. kansaii. [17, 18]. NTMBs are not as contagious
as tuberculosis. Patients with preexisting pul-monary disease, such as chronic obstructive pulmonary disease, and the elderly
are prone to NTMB infections. There are two main forms of presentation: classic and non-classic. The classic form presents
as cavitary disease in the upper zones of the lobes, with symptoms similar to tuber-culosis but no hemoptysis. On imaging,
there are nodules
Figure 9: There are also multiple perilesional nodules (arrows).

Figure 10: Miliary tuberculosis. A 65-year-old female with dyspnea was admitted as her pneumonia was not
improving despite treatment. The CT was performed with a suspicion of pulmonary embolism. The images show
multiple small cavitary nodules in the upper and lower lobes on both sides. Microbiology proved positive for
tuberculosis.

in all lobes, with a slight predilection for the apical and posterior segments. The nodules develop into cavities, as new nodules
also occur. Wall thickness may vary from thin and smooth inner wall to thick and irregular inner wall. The cavitary nodules
are seldom above 2.5 cm in size. Small calcifications may be seen. Mediastinal lymphad-enopathy and pleural effusions are
rare (Figures 11–12). The nonclassic NTMB presents with chronic cough and as a bronchiectatic disease, with centrilobular
nodules and tree-in-bud pattern in relation to the bronchiectasis.
Art. 100, pp.  4 of 8 Parkar and Kandiah: Differential Diagnosis of Cavitary Lung Lesions

Figure 11: Non-tuberculous mycobacterial infection. A 50-year-old male and COPD patient had a routine HRCT exam
that showed small nodules in both lungs (arrows).

Figure 12: The patient returned with cough and malaise a year later. CT showed an increase in the size of the nodules
as well as cavitation. Bronchial lavage produced acid-fast bacilli, later proved to be mycobacterium avium
intracellulare.

Cavitation and mediastinal lymphadenopathy are rare in nonclassic NTMB [18].

Aspergillosis
Aspergillosis is caused by a fungus, Aspergillus fumigatus. Several forms of presentations exist: aspergilloma, aller-gic
bronchopulmonary aspergillosis, chronic necrotizing (formerly semi-invasive) aspergillosis, and invasive asper-gillosis. The
two latter forms are seen in immunocompro-mised hosts, whereas aspergillomas are seen in patients with underlying cavities
in the lungs. In invasive asper-gillosis, the clinical presentation consists of prolonged symptoms of productive cough, fever,
malaise, and some-times hemoptysis [19, 20]. On CT, initially there is con-solidation, sometimes several, which may have a
halo of ground glass surrounding it. The nodules may cavitate (Figures 13–14) [19, 20]. Aspergillomas are not true cavitary
lesions but fungus balls that develop in patients with underlying diseases (tuberculosis, sarcoidosis) with preexisting cavities
in the lungs. They may be completely asymptomatic, when they develop symptoms; the most common is hemoptysis due to
affection of vessels [19, 20]. On imaging, one may find a solitary cavitating or multi-ple cavitating opacities or masses with a
crescent-shaped
Figure 13: Chronic necrotizing (semi-invasive) aspergil-losis. A 70-year-old female with long-standing asthma was
treated with steroids. She was treated for pneumo-nia but still had rising CRP from 140 to 170mg/L. CT revealed a cavitary
nodule in the right upper lobe with ground glass around it, a so-called halo sign (arrows).

Figure 14: The nodule had a thick wall, but a smooth inner wall, and there were no lymph nodes in the medi-astinum.

air collection in the nondependent part of the cavity. The crescent sign must be correlated to the clinical setting of
underlying disease, as the sign is not unique for aspergil-loma [20]. The mobility of the cavity’s contents may be used
to differentiate it from other entities [19]. The wall of the preexisting cavity may be affected by the aspergilloma and
become irregular, but wall thickness usually remains below 3 mm [20]. There may be local pleural thickening (Figure
15) [20].

Systemic Diseases
Granulomatosis with Polyangiitis
Granulomatosis with polyangiitis (GPA) is an autoim-mune disease that causes vasculitis in the small vessels.
Common organs affected are the upper and lower respira-tory tracts and the kidneys. Nosebleeds and hemoptysis
Parkar and Kandiah: Differential Diagnosis of Cavitary Lung Lesions Art. 100, pp.  5 of 8

Figure 15: Aspergilloma. A 58-year-old male sarcoidosis patient also had known long-standing fibrosis. Routine CXR
revealed opacities in the apical segments of both lungs. CT showed large content known fibrotic cysts apically with
crescent-shaped air (short arrows) ante-riorly due to large formed fungus balls (long arrows). There was local pleural
thickening (thick arrow) (no symptoms).

are the most common symptoms, and 95 per cent of all patients present with cough and dyspnea. Imaging reveals large
pulmonary nodules and masses, usually 2–4 cm, and rarely up to 10 cm. Twenty-five per cent of all nodules cavi-tate.
They are often they are located centrally but show no predilection for the upper or lower lungs. The wall thick-ness
may vary considerably. The nodules sometimes have a halo surrounding them which is due to hemorrhage. About half
of the nodules resolve over time in response to treatment; the remaining heal with residual fibrosis (or thin-walled
cysts) or remain unchanged (Figures 16–17) [21, 22]. GPA may also present as ground glass opacities or mosaic
attenuation due to diffuse hemorrhage in the lungs.

Rheumatic Nodules
Cavitating nodular opacities in the course of rheumatic diseases are much rarer than interstitial pulmonary pneu-monias and
vasculitides. The nodules occur when epithe-lial cells cover a necrotic area, creating a necrobiotic nod-ule, which is the cause
of the cavity. These are most often located in the periphery or subpleurally. They may vary in size and wall thickness.
Normally, they are asymptomatic and resolve without specific treatment, but cough and hem-optysis have been reported in
some cases (Figure 18) [23].

Sarcoidosis
Sarcoidosis is a rare differential diagnosis of pulmonary cavitary nodules. Less than 1 per cent of patients with
sarcoidosis develop cavitary nodules. They are reported as rounded or oval-shaped and are usually found in the peri-
hilar or peripheral areas [24].

Malignancies
The most commonly encountered solitary cavitary nod-ule in the lung is a malignant tumor [25]. They may occur
anywhere in the lungs and have round or irregular shapes with a great variation in wall thickness. Wall thickness
greater than 24 mm as well as perilesional consolida-tion may indicate malignancy, as mentioned earlier [18]. Of all
bronchial carcinomas, 10–15 per cent are cavitary (Figures 19–20).
Figures 16–17: Granulomatosis with polyangiitis. A 74-year-old female was admitted due to dyspnea and productive cough,
but no fever. The CT images show relatively large cavitary lesion in both lungs with thick, irregular walls (thick arrows).
Three years later, the nod-ules had evolved into a cyst on the right side. On the left side, the nodule was smaller and no
longer cavitary.

Figure 18: Rheumatic nodule. A 46-year-old male with long-standing rheumatoid arthritis was immunosup-pressed due
to ongoing methotrexate treatment. CT was requested for chronic cough. The CT showed mul-tiple centrilobular
nodules in the left lung (inside the marked area), which were bronchiolitis due to his RA. In addition, a subplueral
cavitary nodule is seen (thick arrow). A month later, the nodule was slowly dissipating (arrow).

Pulmonary metastasis from squamous cell carcinomas, mainly from the gastrointestinal tract and breast, sarco-mas, and
adenocarcinomas frequently cavitate (Figure 21)
[26]. On imaging, differentiating malignant tumors from other cavitary entities may be difficult, but the clinical his-
tory of weight loss and lack of acute symptoms such as fever may be helpful.
Art. 100, pp.  6 of 8 Parkar and Kandiah: Differential Diagnosis of Cavitary Lung Lesions

Figure 19: Lung cancer. A 65-year-old female patient with a smoking history of 50 years was admitted with hem-
optysis and malaise, no fever. CT showed a large cavitary lesion with varying wall thickness. Note that without the
clinical history this case is impossible to differenti-ate from the case presented in Figure 1.

Figure 20: Lung cancer. A 70-year-old male patient was admitted due to dyspnea when supine, no fever or cough. In
the left upper lobe, a mostly thin-walled multicystic lesion is seen, with a short thicker wall in-between (arrows). A
biopsy proved adenocarcinoma.

Figure 21: Metastasis. Pulmonary nodules with small and large cavitary components (arrows) are shown, which were
metastases from an adenocarcinoma in the pan-creas (not shown).

Entities That Overlap with Cystic Diseases

Langerhans cell histiocytosis (LCH), lymphangioleiomy-omatosis (LAM), lymphocytic interstitial pneumonia (LIP), and
findings of pneumocystis jirovecii infection are all cystic lung diseases (Figures 22–26). Cystic bronchiectasis
Figure 22: LAM. An 84-year-old female, previously oper-ated on for an angiomyolipoma, was admitted with dyspnea.
CT showed multiple thin-walled cysts with varying sizes.

Figure 23: LIP. A 71-year-old female with systemic lupus erythematosus for decades was admitted with increas-ing
dyspnea and chronic cough, prompting a CT request. Thin-walled cysts are seen on the right and left sides (arrows).
Diagnosis was LIP, which is associated with SLE.

Figure 24: Pneumocystis jirovecii infection. A 40-year-old male was admitted with acute dyspnea. An initial CT was
done for suspected PE. It showed extensive ground glass opacities in both lungs and a small con-solidation in the right
upper lobe. The patient was subsequently diagnosed with acquired immunode-ficiency. One month later (HRCT) the
ground glass is less extensive, and the nodule has developed into a thin-walled cyst.
Parkar and Kandiah: Differential Diagnosis of Cavitary Lung Lesions Art. 100, pp.  7 of 8

Figures 25–26: Cystic bronchiectases. A 51-year-old male was admitted with abdominal pain. An incidental find-ing
in the basal lung right side showed cysts (grape-like clusters) with direct connection to the bronchial system (long
arrow). The severe but unilateral affec-tion excluded a systemic disease and was consistent with cystic
bronchiectases, probably secondary to an infection.

may also be a differential diagnosis. However, wall thick-ness as well as clinical findings are important criteria to
differentiate between cavitary and cystic lung diseases [27, 28, 29, 30, 31].

Conclusion
To summarize, cavitary pulmonary lesions are caused by a number of varying disease entities. Paying close attention to
disease-specific CT findings combined with the clinical history and findings are important tools leading to the correct
diagnosis.

Competing Interests
The authors have no competing interests to declare.

References
1. Hansell, DM, Bankier, AA, MacMahon, H, McLoud, TC, Müller, NL and Remy, J. Fleischner Society:
glossary of terms for thoracic imaging. Radiology. 2008; 246: 697–672. DOI: http://dx.doi.
org/10.1148/radiol.2462070712
2. Guo, J, Liang, C, Sun, Y, Zhou, N, Liu, Y and Chu, X. Lung cancer presenting as thin-walled cysts: An
analysis of 15 cases and review of literature. Asia Pac J Clin Oncol. 2016; 12: 105–112. DOI: http://
dx.doi.org/10.1111/ajco.12126
 3. Nin, CS, de Souza, VV, Alves, GR, et al. Solitary lung cavities: CT findings in malignant and non-malignant
disease [epub ahead of print]. Clin Radiol. 2016. DOI: http://dx.doi.org/10.1016/j. crad.2016.04.009
4. Park, Y, Kim, TS, Yi, CA, Cho, EY, Kim, H and Choi, YS. Pulmonary cavitary mass containing a mural nodule:
Differential diagnosis between intra-cavitary aspergilloma and cavitating lung cancer on contrast-enhanced
computed tomography. Clin Radiol. 2007; 62: 227–232. DOI: http://dx.doi. org/10.1016/j.crad.2006.11.001
5. Swensen, SJ, Viggiano, RW, Midthun, DE, et al. Lung nodule enhancement at CT: Multicenter study. Radiology. 2000;
214: 73–80. DOI: http://dx.doi. org/10.1148/radiology.214.1.r00ja1473
6. Walker, CM, Abbott, GF, Greene, RE, et al. Imaging pulmonary infection: Classic signs and patterns. AJR Am J
Roentgenol. 2014; 202: 479–492. DOI: http:// dx.doi.org/10.2214/AJR.13.11463
7. Murata, K, Takahashi, M, Mori, M, et al. Pulmo-nary metastatic nodules: CT-pathologic correlation. Radiology.
1992; 182: 331–335. DOI: http://dx.doi. org/10.1148/radiology.182.2.1732945
8. Akinosoglou, KS, Karkoulias, K and Marangos, M. Infectious complications in patients with lung can-cer. Eur Rev
Med Pharmacol Sci. 2013; 17: 8–18.
9. Gadkowski, LB and Stout, JE. Cavitary pulmonary disease. Clin Microbiol Rev. 2008; 21: 305–333. DOI:
http://dx.doi.org/10.1128/CMR.00060-07
10. Reynolds, JH, McDonald, G, Alton, H and Gordon, SB. Pneumonia in the immunocompe-tent patient. Br J
Radiol. 2010; 83: 998–1009. DOI: http://dx.doi.org/10.1259/bjr/31200593
11. Yunus, M. CT guided transthoracic catheter drain-age of intrapulmonary abscess. J Pak Med Assoc. 2009; 59:
703–709.
12. Han, D, Lee, KS, Franquet, T, et al. Thrombotic and nonthrombotic pulmonary arterial embolism: Spectrum of imaging
findings. Radiographics. 2003;
23: 1521–1539. DOI: http://dx.doi.org/10.1148/ rg.1103035043
13. Cook, RJ, Ashton, RW, Aughenbaugh, GL and Ryu, JH. Septic pulmonary embolism: Present-ing features and
clinical course of 14 patients. Chest. 2015; 128: 162–166. DOI: http://dx.doi. org/10.1378/chest.128.1.162
14. Prapruttam, D, Hedgire, SS, Mani, SE, et al. Tuberculosis—the great mimicker. Semin Ultrasound CT MR.
2014; 35: 195–214. DOI: http://dx.doi. org/10.1053/j.sult.2014.02.002
15. Burrill, J, Williams, CJ, Bain, G, et al. Tubercu-losis: A radiologic review. Radiographics. 2007;
27: 1255–1273. DOI: http://dx.doi.org/10.1148/ rg.275065176
16. Rozenshtein, A, Hao, F, Starc, MT and Pearson, GD. Radiographic appearance of pulmonary tuberculo-sis: Dogma
disproved. AJR Am J Roentgenol. 2015;
204: 974–978. DOI: http://dx.doi.org/10.2214/ AJR.14.13483
Art. 100, pp.  8 of 8 Parkar and Kandiah: Differential Diagnosis of Cavitary Lung Lesions

17. Griffith, DE, Aksamit, T, Brown-Elliott, BA, et al. An official ATS/IDSA statement: Diagnosis, treat-ment,
and prevention of nontuberculous myco-bacterial diseases. Al j Respir Crit Care Med. 2007;
175: 367–416. DOI: http://dx.doi.org/10.1164/ rccm.200604-571ST
18. Erasmus, JJ, McAdams, HP, Farrell, MA and Jr. Patz, EF. Pulmonary nontuberculous mycobacte-rial
infection: Radiologic manifestations. Radio-graphics. 1999; 19: 1487–1505. DOI: http://dx.doi.
org/10.1148/radiographics.19.6.g99no101487
19. Chabi, ML, Goracci, A, Roche, N, et al. Pulmo-nary aspergillosis. Diagn Interv Imaging. 2015;
96: 435–442. DOI: http://dx.doi.org/10.1016/j. diii.2015.01.005
20. Franquet, T, Müller, NL, Oikonomou, A and Flint, JD. Aspergillus infection of the airways: Com-puted
tomography and pathologic findings. J Com-put Assist Tomogr. 2004; 28: 10–16. DOI: http://
dx.doi.org/10.1097/00004728-200401000-00002
21. Castañer, E, Alguersuari, A, Andreu, M, et al. Imaging findings in pulmonary vasculitis. Semin Ultrasound
CT MR. 2012; 33: 567–579. DOI: http:// dx.doi.org/10.1053/j.sult.2012.05.001
22. Feragalli, B, Mantini, C, Sperandeo, M, et al. The lung in systemic vasculitis: Radiological pat-terns and
differential diagnosis. Br J Radiol. 2016;
89: 20150992. DOI: http://dx.doi.org/10.1259/ bjr.20150992
23. Chanin, K, Vallejo-Manzur, F, Sternbach, GL,
Fromm, R and Varon, J. Pulmonary manifestations of rheumatoid arthritis. Hospital Physician. 2001;
37: 23–28.
24. Park, HJ, Jung, JI, Chung, MH, et al. Typical and atypical manifestations of intrathoracic sarcoidosis.
 Korean J Radiol. 2009; 10: 623–631. DOI: http:// dx.doi.org/10.3348/kjr.2009.10.6.623
25. Ryu, JH and Swensen, SJ. Cystic and cavitary lung diseases: Focal and diffuse. Mayo Clin Proc. 2003; 78: 744–752.
DOI: http://dx.doi.org/10.4065/78.6.744
26. Seo, JB, Im, JG, Goo, JM, Chung, MJ and Kim, MY. Atypical pulmonary metastases: Spec-trum of radiologic
findings. Radiographics. 2012;
21: 403–417. DOI: http://dx.doi.org/10.1148/ radiographics.21.2.g01mr17403
27. Hidalgo, A, Franquet, T, Giménez, A, Bordes, R, Pineda, R and Madrid, M. Smoking-related inter-stitial lung
diseases: radiologic-pathologic correla-tion. Eur Radiol. 2006; 16: 2463–2470. DOI: http://
dx.doi.org/10.1007/s00330-006-0340-0
28. Abbott, GF, Rosado-de-Christenson, ML,
Frazier, AA, et al. From the archives of the AFIP: Lymphangioleiomyomatosis: Radiologic-pathologic correlation.
Radiographics. 2005; 25: 803–828. DOI: http://dx.doi.org/10.1148/rg.253055006
29. Carrillo, J, Restrepo, CS, Rosado de Christenson, M, et al. Lymphoproliferative lung disorders: A radiologic-
pathologic overview. Part I: Reactive disorders. Semin Ultrasound CT MR. 2013;
4: 525–534. DOI: http://dx.doi.org/10.1053/j. sult.2013.05.002
30. Chong, S, Lee, KS, Yi, CA, Chung, MJ, Kim, TS and Han, J. Pulmonary fungal infection: Imaging find-ings in
immunocompetent and immunocompro-mised patients. Eur J Radiol. 2006; 59: 371–383. DOI:
http://dx.doi.org/10.1016/j.ejrad.2006.04.017
31. Cantin, L, Bankier, AA and Eisenberg, RL. Bronchiectasis. AJR Am J Roentgenol. 2009; 193: W158–171. DOI:
http://dx.doi.org/10.2214/ AJR.09.3053

How to cite this article: Parkar, A P and Kandiah, P 2016 Differential Diagnosis of Cavitary Lung Lesions. Journal of the
Belgian Society of Radiology, 100(1): 100, pp. 1–8, DOI: http://dx.doi.org/10.5334/jbr-btr.1202

Published: 19 November 2016

Copyright: © 2016 The Author(s). This is an open-access article distributed under the terms of the Creative Commons
Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.
Journal of the Belgian Society of Radiology is a peer-reviewed open access journal published by Ubiquity Press.
OPEN ACCESS